We hypothesized that quercetin-mediated inhibition of cardiac hypertrophy would be accompanied by increased activation of PPAR-γ and reduced activation of AP-1 (c-fos, c-jun) both in vivo and in vitro. The gene discussed is JUN; the disease is cardiac hypertrophy.